Laboratory Corporation of America Holdings (LabCorp) (LH) Completes and Publishes a Clinical Study for the Development and Validation of a PCR Assay for the Diagnosis of Bacterial Vaginosis
8/7/2012 10:21:17 AM
BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the publication in the July 2012 Journal of Clinical Microbiology of a clinical study that supports validation of a new clinical diagnostic test for bacterial vaginosis. These studies were completed under IRB approval in collaboration with the Department of Medicine, University of Alabama at Birmingham School of Medicine, and the article was co-authored by physicians and scientists from both organizations.
comments powered by